← Back to Search
Engineering The Nanoparticle-protein Interface For Cancer Therapeutics.
A. Saie, M. Ray, M. Mahmoudi, V. Rotello
Published 2015 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Intracellular delivery of functional proteins using nanoparticles can be a game-changing approach for cancer therapy. However, cytosolic release of functional protein is still a major challenge. In addition, formation of protein corona on the surface of the nanoparticles can also alter the behavior of the nanoparticles. Here, we will review recent strategies for protein delivery into the cell. Finally we will discuss the issue of protein corona formation in light of nanoparticle-protein interactions.
This paper references
Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics.
Susumu Nagayama (2007)
Biological characterization of L-asparaginase liposomal formulations
M. M. Gaspar (1996)
Effect of serum proteins on polystyrene nanoparticle uptake and intracellular trafficking in endothelial cells
D. Guarnieri (2011)
Size and geometry dependent protein-nanoparticle self-assembly.
Mrinmoy De (2009)
An endotoxin-induced serum factor that causes necrosis of tumors.
E. Carswell (1975)
Fibrinogen Promotes Neutrophil Activation and Delays Apoptosis1
C. Rubel (2001)
Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine.
S. Libutti (2009)
Synthetic "chaperones": nanoparticle-mediated refolding of thermally denatured proteins.
Mrinmoy De (2008)
Multiplexed imaging of nanoparticles in tissues using laser desorption/ionization mass spectrometry.
B. Yan (2013)
Temperature: the "ignored" factor at the NanoBio interface.
M. Mahmoudi (2013)
Protein delivery using engineered virus-like particles
S. J. Kaczmarczyk (2011)
The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells.
T. R. Daniels (2006)
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
Christian A. Ruge (2011)
In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon-γ and melphalan in isolation perfusion
D. Liénard (2005)
Identification of rat yolk sac target protein of teratogenic antibodies, gp280, as intrinsic factor-cobalamin receptor.
B. Seetharam (1997)
Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response.
G. Maiorano (2010)
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
G. Paciotti (2004)
Tunable inhibition and denaturation of alpha-chymotrypsin with amino acid-functionalized gold nanoparticles.
Chang-Cheng You (2005)
A draft map of the human proteome
Min-Sik Kim (2014)
Plasma concentration gradient influences the protein corona decoration on nanoparticles
Mahdi Ghavami (2013)
Liposomal palmitoyl-L-asparaginase: characterization and biological activity
J. Jorge (2004)
Peptide and protein drug delivery to and into tumors: challenges and solutions.
V. Torchilin (2003)
High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer.
F. Lejeune (1995)
Role of extracellular matrix assembly in interstitial transport in solid tumors.
P. A. Netti (2000)
Fabrication of multiresponsive bioactive nanocapsules through orthogonal self-assembly.
Yi-Cheun Yeh (2014)
Significance of cell "observer" and protein source in nanobiosciences.
S. Laurent (2013)
Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush.
D. Labarre (2005)
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
Jie Gao (2009)
Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab′) fragments
Jie Gao (2008)
Complement C3 participation in monocyte adhesion to different surfaces.
A. K. McNally (1994)
Size and dynamics of caveolae studied using nanoparticles in living endothelial cells.
Zhenjia Wang (2009)
Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma.
P. Anderson (1994)
Development of amphiphilic gamma-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier.
T. Yoshikawa (2008)
Particulate delivery systems for biodefense subunit vaccines.
Vincent W. Bramwell (2005)
DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs.
Qiaoming Ye (2000)
Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.
Carl D. Walkey (2012)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
M. Cheever (2011)
Effect of pegylation on pharmaceuticals
J. Harris (2003)
Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy.
L. Folkes (2001)
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation.
Z. Deng (2011)
The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles.
Zheng-Jiang Zhu (2012)
Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects.
Y. Li (2001)
Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes.
R. Sitrin (1998)
Efficient encapsulation of proteins within liposomes for slow release in vivo.
J. Meyer (1994)
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
V. Zannis (2005)
Protein corona significantly reduces active targeting yield.
Vahid Mirshafiee (2013)
Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.
Suzanne R. Foster (2010)
Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein.
Mrinmoy De (2009)
Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity.
L. Kwak (1998)
On the adsorption of proteins on solid surfaces, a common but very complicated phenomenon.
K. Nakanishi (2001)
Functional groups on polystyrene model nanoparticles: influence on protein adsorption.
A. Gessner (2003)
Identification of human plasma proteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency: implications for intravenous gene transfer.
Bouna-Moussa Tandia (2003)
Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsules.
R. Tang (2013)
An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
D. Wakita (2006)
ABCA1 and Scavenger Receptor Class B, Type I, Are Modulators of Reverse Sterol Transport at an in Vitro Blood-Brain Barrier Constituted of Porcine Brain Capillary Endothelial Cells*
U. Panzenboeck (2002)
Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen
S. Neelapu (2004)
Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL‐associated vitamin E
D. Goti (2001)
Effect of gold nanoparticle morphology on adsorbed protein structure and function.
Jennifer E. Gagner (2011)
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
S. Laurent (2014)
The transferrin receptor: a potential molecular imaging marker for human cancer.
Dagmar Högemann-Savellano (2003)
Enhancing Endosomal Escape of Transduced Proteins by Photochemical Internalisation
K. Mellert (2012)
Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
Manas Mandal (2002)
Liposomal drug delivery systems: from concept to clinical applications.
T. Allen (2013)
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells.
A. Leśniak (2012)
Scavenger receptor class B type I expression in murine brain and regulation by estrogen and dietary cholesterol
R. Srivastava (2003)
Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions.
Shengtao Yang (2013)
Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4 nanoparticles
Avinash Bajaj (2009)
Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
C. Choi (2013)
Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids
L. Vroman (1962)
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".
E. Mahon (2012)
Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles.
S. M. Lim (2011)
A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture).
E. Kanaoka (2002)
Protein misfolding, functional amyloid, and human disease.
F. Chiti (2006)
Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.
Jongho Kim (2008)
Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release.
Anna Cifuentes-Rius (2013)
140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.
T. Berggård (2006)
Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins
Y. Zhang (2012)
Gold nanoparticles in chemical and biological sensing.
K. Saha (2012)
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.
M. Monopoli (2011)
Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles.
M. Mahmoudi (2013)
Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum.
G. Caracciolo (2010)
Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity
Daniel F. Moyano (2014)
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
Modulation of the catalytic behavior of alpha-chymotrypsin at monolayer-protected nanoparticle surfaces.
Chang-Cheng You (2006)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
Large Protein Absorptions from Small Changes on the Surface of Nanoparticles
M. Mahmoudi (2011)
Transferrin Coated Nanoparticles: Study of the Bionano Interface in Human Plasma
A. S. Pitek (2012)
The intrinsic factor–vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein
R. Kozyraki (1999)
Heterogeneity of tumor cells from a single mouse mammary tumor.
D. Dexter (1978)
Evolution of the protein corona of lipid gene vectors as a function of plasma concentration.
G. Caracciolo (2011)
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.
A. Salvati (2013)
Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis.
S. Hammad (1999)
The mechanism of indole acetic acid cytotoxicity.
M. P. de Melo (2004)
Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.
I. Hamad (2010)
Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor‐targeted drug delivery vectors
G. Paciotti (2006)
Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line.
Oleg Lunov (2011)
MARCO Mediates Silica Uptake and Toxicity in Alveolar Macrophages from C57BL/6 Mice*
R. Hamilton (2006)
Contrasting effects of exterior and interior hydrophobic moieties in the complexation of amino acid functionalized gold clusters with alpha-chymotrypsin.
Chang-Cheng You (2005)
The protein corona effect for targeted drug delivery
G. Caracciolo (2013)
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles.
T. Cedervall (2007)
Supramolecular tailoring of protein-nanoparticle interactions using cucurbituril mediators.
Yi-Cheun Yeh (2014)
Clinical impact of serum proteins on drug delivery.
F. Kratz (2012)
Therapeutic potential of cell-penetrating peptides.
L. Vasconcelos (2013)
Effects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticles
Y. Zhu (2009)
Exploiting the protein corona around gold nanorods for loading and triggered release.
J. Kah (2012)
Characterization of a 280-kD protein restricted to the coated pits of the renal brush border and the epithelial cells of the yolk sac. Teratogenic effect of the specific monoclonal antibodies
D. Sahali (1988)
Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion.
P. Daftarian (2006)
Personalized protein coronas: a "key" factor at the nanobiointerface.
M. Hajipour (2014)
NMR studies of lipoprotein structure.
R. J. Cushley (2002)
Time evolution of the nanoparticle protein corona.
E. Casals (2010)
Liposomes-mediated delivery of pro-apoptotic therapeutic membrane proteins.
L. Liguori (2008)
Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles.
A. Paula (2013)
Size and shape effects in the biodistribution of intravascularly injected particles.
P. Decuzzi (2010)
Protein-nanoparticle interactions: opportunities and challenges.
M. Mahmoudi (2011)
Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling
C. Roy (2005)
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.
S. Tenzer (2013)
Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
Raymond P. Briñas (2012)
Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles.
P. Ghosh (2010)
Tumor Cell Killing Enabled by Listeriolysin O-liposome-mediated Delivery of the Protein Toxin Gelonin*
C. Provoda (2003)
Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding
X. Jiang (2009)
A novel intracellular protein delivery platform based on single-protein nanocapsules.
Ming Yan (2010)
Lung macrophage uptake of unopsonized environmental particulates. Role of scavenger-type receptors.
L. Kobzik (1995)
Tumor Vascular Endothelium: Barrier or Target in Tumor Directed Drug Delivery and Immunotherapy
G. Molema (2004)
This paper is referenced by
Investigation of nanoparticle toxicity: Characterization of protein corona and evaluation of oxidative stress by protein carbonylation
Marc D. Driessen (2016)
Nanoparticle-Protein Interactions: Therapeutic Approaches and Supramolecular Chemistry.
M. Kopp (2017)
Die Steuerung des Stealth‐Effekts von Nanoträgern durch das Verständnis der Proteinkorona
S. Schöttler (2016)
Protein corona: Opportunities and challenges.
S. Zanganeh (2016)
Ultraviolet Photodissociation of Selected Gold Clusters: Ultraefficient Unstapling and Ligand Stripping of Au25(pMBA)18 and Au36(pMBA)24.
D. Black (2017)
Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells
N. Chaves (2017)
3D RNA nanocage for encapsulation and shielding of hydrophobic biomolecules to improve the in vivo biodistribution
Congcong Xu (2020)
Gold nanoparticles partition to and increase the activity of glucose-6-phosphatase in a synthetic phospholipid membrane system
T. MacCormack (2017)
Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.
S. Schöttler (2016)
Effects of Nanoparticle Electrostatics and Protein-Protein Interactions on Corona Formation: Conformation and Hydrodynamics.
Hwankyu Lee (2020)
Combined photothermal and antibiotic therapy for bacterial infection via acidity-sensitive nanocarriers with enhanced antimicrobial performance
Danfeng He (2018)
Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Zahra Bakhtiary (2016)
The protein corona of polymeric nanocarriers: characterization and impact on cellular uptake
S. Schöttler (2015)
Protein Corona: The Challenge at the Nanobiointerfaces
S. Zanganeh (2018)
Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
N. Ignjatović (2016)
Electrostatic attraction driven and shuttle-like morphology assisted enhancement for tumor uptake
Min Lin (2017)
The biomolecular corona of nanoparticles in circulating biological media.
D. Pozzi (2015)
Galectin-1 inhibitors and their potential therapeutic applications: a patent review
H. Blanchard (2016)